Search hospitals
>
Iowa
>
Iowa City
University of Iowa/Holden Comprehensive Cancer Center
Claim this profile
Iowa City, Iowa 52242
Global Leader in Cancer
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Ovarian Cancer
Conducts research for Lung Cancer
639 reported clinical trials
42 medical researchers
Summary
University of Iowa/Holden Comprehensive Cancer Center is a medical facility located in Iowa City, Iowa. This center is recognized for care of Cancer, Lymphoma, Leukemia, Ovarian Cancer, Lung Cancer and other specialties. University of Iowa/Holden Comprehensive Cancer Center is involved with conducting 639 clinical trials across 646 conditions. There are 42 research doctors associated with this hospital, such as David S. Dickens, Mariko Sato, Muhammad Furqan, and Yousef Zakharia, MD.
Area of expertise
Cancer
University of Iowa/Holden Comprehensive Cancer Center has run 80 trials for Cancer. Some of their research focus areas include:
Lymphoma
University of Iowa/Holden Comprehensive Cancer Center has run 64 trials for Lymphoma. Some of their research focus areas include:
Top PIs
David S. Dickens
University of Iowa/Holden Comprehensive Cancer Center
8 years of reported clinical research
Mariko Sato
University of Iowa/Holden Comprehensive Cancer Center
8 years of reported clinical research
Muhammad Furqan
University of Iowa Healthcare Cancer Services Quad Cities
2 years of reported clinical research
Yousef Zakharia, MD
University of Iowa Hospitals and Clinics
7 years of reported clinical research
Clinical Trials running at University of Iowa/Holden Comprehensive Cancer Center
Cancer
Ovarian Cancer
Breast Cancer
Prostate Cancer
Bladder Cancer
Acute Myeloid Leukemia
Bladder Carcinoma
Breast cancer
Testicular cancer
Cervical Cancer
Olanzapine vs Megestrol Acetate
for Cancer-Related Anorexia
This trial tests whether olanzapine or megestrol acetate is better at increasing appetite in patients with advanced cancer. These patients often struggle with eating and weight loss. Both medications aim to make them feel hungrier, helping them eat more and gain weight. Megestrol acetate is known for its effectiveness in increasing appetite in patients with cancer.
Recruiting
2 awards
Phase 3
1 criteria
Text-Based Smoking Cessation Program
for Rural Cancer Survivors
This phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based scheduled gradual reduction may reduce the frequency of cigarette use to zero and may be effective in quitting smoking.
Recruiting
2 awards
Phase 3
Triptorelin
for Cancer
This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. If the ovaries are not working well or completely shut down, then it will be difficult or impossible to get pregnant in the future. Triptorelin works by blocking certain hormones and causing the ovaries to slow down or pause normal activity. The triptorelin used in this study stays active in the body for 24 weeks or about 6 months after a dose is given. After triptorelin is cleared from the body, the ovaries resume normal activities. Adding triptorelin before the start of chemotherapy treatment may reduce the chances of damage to the ovaries.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Iowa/Holden Comprehensive Cancer Center?
University of Iowa/Holden Comprehensive Cancer Center is a medical facility located in Iowa City, Iowa. This center is recognized for care of Cancer, Lymphoma, Leukemia, Ovarian Cancer, Lung Cancer and other specialties. University of Iowa/Holden Comprehensive Cancer Center is involved with conducting 639 clinical trials across 646 conditions. There are 42 research doctors associated with this hospital, such as David S. Dickens, Mariko Sato, Muhammad Furqan, and Yousef Zakharia, MD.
Where is University of Iowa/Holden Comprehensive Cancer Center located?
The University of Iowa Holden Comprehensive Cancer Center is situated at 200 Hawkins Dr., 7970 JPP, Iowa City, IA. For directions, take I-80 W to exit 242 for US-218 S toward Iowa City, continue on US-218 S to Dubuque St, turn right onto Dubuque St, and then left onto Hawkins Dr to reach the center.
Who should I call to ask about financial aid or insurance network?
**University of Iowa Hospitals & Clinics Financial and Billing Assistance:** - To be eligible for financial assistance, individuals must: - Be a documented resident of Iowa. - Have an income at or below 350% of the Federal Income Poverty Guidelines. - Provide proof of income. - Comply with the Medicaid eligibility process with UI Health Care social workers or designated on-site representatives. - For insurance-related questions, contact UI Health Care Financial Counseling at 319-338-2111. - Holden Comprehensive Cancer Center offers oncology social workers to assist during the cancer treatment journey. For assistance, talk to your provider or call 1-800-777-8442. The financial management team ensures cancer treatments are covered by insurance, including preauthorization for medications and treatments.
What insurance does University of Iowa/Holden Comprehensive Cancer Center accept?
The University of Iowa/Holden Comprehensive Cancer Center accepts various insurance plans. Coverage details depend on the individual's insurance carrier and plan, so it's crucial to verify with your provider. Payments, including co-payments, can be made using Visa, MasterCard, Discover, or American Express.
What awards or recognition has University of Iowa/Holden Comprehensive Cancer Center received?
The Holden Comprehensive Cancer Center at the University of Iowa, recognized by the National Cancer Institute as a comprehensive cancer center since 2000, exemplifies excellence in cancer research and care. It has been awarded numerous grants, including SPORE grants for lymphoma and neuroendocrine tumors. The center's innovative MOGs program assembles multidisciplinary teams to offer personalized care, alongside a robust selection of clinical trials advancing cancer medicine.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.